Clostridiales Family XIV Incertae Sedis
The marker "Clostridiales Family XIV Incertae Sedis" pertains to a specific, yet not fully classified, group within the Clostridiales order, underlining the complexity and ongoing exploration in the realm of gut microbiota research. This group, labeled "Incertae Sedis," meaning "of uncertain placement," comprises bacteria that have not yet been definitively categorized into a known family due to the current limitations in bacterial taxonomy and the rapid evolution of genomic sequencing technologies. These microorganisms, residing in the human gastrointestinal tract, are anaerobic and predominantly Gram-positive. They play a pivotal role in the gut ecosystem, primarily involved in the fermentation of dietary fibers and the resultant production of short-chain fatty acids (SCFAs), like butyrate, propionate, and acetate. These SCFAs are crucial for maintaining gut barrier integrity, modulating immune responses, and providing energy to colonocytes. The presence and relative abundance of this group can yield insights into the gut's health and microbial diversity. Imbalances in these bacteria, either overgrowth or underrepresentation, can be indicative of gut dysbiosis and have been linked to various gastrointestinal disorders, such as inflammatory bowel disease, irritable bowel syndrome, and colorectal cancer.
Lab Results Explained and Tracked
All Your Lab Results.
One Simple Dashboard.
Import, Track, and Share Your Lab Results Easily
Import, Track, and Share Your Lab Results
Import lab results from multiple providers, track changes over time, customize your reference ranges, and get clear explanations for each result. Everything is stored securely, exportable in one organized file, and shareable with your doctor—or anyone you choose.
Cancel or upgrade anytime
What does it mean if your Clostridiales Family XIV Incertae Sedis result is too low?
Low levels of the Clostridiales Family XIV Incertae Sedis in the gut may indicate an imbalance in the gut microbiome. This group of bacteria is involved in crucial processes like the fermentation of dietary fibers and the production of short-chain fatty acids (SCFAs), which are vital for maintaining the health of the gut lining, modulating the immune system, and overall colon health. Reduced levels of these bacteria can lead to a decrease in SCFA production, potentially resulting in compromised gut barrier integrity, increased gut inflammation, and a disruption in normal gut functioning.
Treatment and management of low levels typically focus on dietary and lifestyle changes to enhance the growth of these beneficial bacteria. This includes increasing the intake of fiber-rich foods, such as fruits, vegetables, and whole grains, which act as prebiotics to stimulate the growth of healthy gut bacteria. Fermented foods, which are natural sources of probiotics, can also be beneficial. In some cases, a healthcare provider might recommend specific probiotic supplements that can help in increasing the levels of these beneficial bacteria.
Moreover, lifestyle modifications such as regular physical activity, stress management, and adequate sleep are important for maintaining overall gut health. Avoidance of unnecessary antibiotics and other medications that can harm beneficial gut bacteria is also crucial.
It's important to note that the interpretation of these results and the formulation of a treatment plan should be conducted by a healthcare professional. They can provide a tailored approach based on the individual's overall health, lifestyle, and specific needs, ensuring the most effective and safe strategy for addressing low levels of Clostridiales Family XIV Incertae Sedis.
---------
A recent study has also shown that a reduction in the abundance of Clostridiales Incertae Sedis XI is associated with risk of nosocomial CDI and may represent a target for novel strategies to prevent this life-threatening infection. [L]
Nosocomial Clostridium difficile infection (CDI) refers to infections caused by the bacterium Clostridium difficile (now known as Clostridioides difficile) acquired in healthcare settings, such as hospitals and long-term care facilities. This pathogen is particularly concerning in these environments due to its ability to cause severe diarrhea, colitis, and in extreme cases, life-threatening complications. CDI often occurs after the use of antibiotics that disrupt the normal gut flora, allowing C. difficile to proliferate. The bacterium produces toxins that damage the lining of the intestines, leading to its characteristic symptoms. Nosocomial CDI is a major healthcare challenge due to its high rates of recurrence and the increasing prevalence of antibiotic-resistant strains. Management includes discontinuing the inciting antibiotic when possible, initiating appropriate antibiotic therapy for C. difficile, and implementing strict infection control measures to prevent its spread, such as hand hygiene and isolation protocols. In recurrent cases, treatments may extend to fecal microbiota transplantation to restore a healthy gut microbiome.
Article Review & Sources
All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We're committed to accuracy and transparency — see our editorial policy for details.
Laboratories
Bring All Your Lab Results Together — In One Place
We accept reports from any lab, so you can easily collect and organize all your health information in one secure spot.
Pricing Table
Gather Your Lab History — and Finally Make Sense of It
Finally, Your Lab Results Organized and Clear
Personal plans
$79/ year
Advanced Plan
Access your lab reports, explanations, and tracking tools.
- Import lab results from any provider
- Track all results with visual tools
- Customize your reference ranges
- Export your full lab history anytime
- Share results securely with anyone
- Receive 5 reports entered for you
- Cancel or upgrade anytime
$250/ once
Unlimited Account
Pay once, access everything—no monthly fees, no limits.
- Import lab results from any provider
- Track all results with visual tools
- Customize your reference ranges
- Export your full lab history anytime
- Share results securely with anyone
- Receive 10 reports entered for you
- No subscriptions. No extra fees.
$45/ month
Pro Monthly
Designed for professionals managing their clients' lab reports
- Import lab results from any provider
- Track lab results for multiple clients
- Customize reference ranges per client
- Export lab histories and reports
- Begin with first report entered by us
- Cancel or upgrade anytime
About membership
What's included in a Healthmatters membership
Import Lab Results from Any Source
See Your Health Timeline
Understand What Your Results Mean
Visualize Your Results
Data Entry Service for Your Reports
Securely Share With Anyone You Trust
Let Your Lab Results Tell the Full Story
Once your results are in one place, see the bigger picture — track trends over time, compare data side by side, export your full history, and share securely with anyone you trust.
Bring all your results together to compare, track progress, export your history, and share securely.
What Healthmatters Members Are Saying
We implement proven measures to keep your data safe.
At HealthMatters, we're committed to maintaining the security and confidentiality of your personal information. We've put industry-leading security standards in place to help protect against the loss, misuse, or alteration of the information under our control. We use procedural, physical, and electronic security methods designed to prevent unauthorized people from getting access to this information. Our internal code of conduct adds additional privacy protection. All data is backed up multiple times a day and encrypted using SSL certificates. See our Privacy Policy for more details.